-
1 Comment
Towa Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 14.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Towa Pharmaceutical Co., Ltd's total revenue rose by 39.8% to $41B since the same quarter in the previous year.
Its net income has dropped by 18.1% to $3B since the same quarter in the previous year.
Based on the above factors, Towa Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Sector | Healthcare |
| ISIN | JP3623150004 |
| Exchange | TSE |
| CurrencyCode | JPY |
| Target Price | 3860 |
|---|---|
| Beta | -0.23 |
| Dividend Yield | 3.0% |
| Market Cap | 128B |
| PE Ratio | 6.62 |
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4553.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
